[Differential, oncologically adequate therapy of basalioma] Handchirurgie, Mikrochirurgie, plastische Chirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft für Handchirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft für Mikrochirurgie der Peripheren Nerven und Gefässe : Organ der Vereinigung der Deutschen Plastischen Chirurgen. [Handchir Mikrochir Plast Chir] Journal article

Title	[Differential, oncologically adequate therapy of basalioma]
Author(s)	Germann G, Bernstein-Sommer B, Petrovici V, Steinau HU
Institution	Abteilúng für Plastische Chirurgie, Handchirurgie-Schwerverbranntenzentrum, BG-Universitätsklinik Bergmannsheil, Bochum.
Source	Handchir Mikrochir Plast Chir 1992 May; 24(3):151-8.
MeSH	Adult Aged Aged, 80 and over Carcinoma, Basal Cell English Abstract Female Follow-Up Studies Head and Neck Neoplasms Humans Male Middle Aged Neoplasm Recurrence, Local Skin Skin Neoplasms Surgical Flaps Suture Techniques
Abstract	Surgical treatment of basal cell carcinoma demands straightforward tumor management. This study investigated the radicality of surgical excision, procedures performed for defect coverage, the recurrency rate depending on the histological tumor type, among other parameters. Despite a low general incidence of 14%, sclerodermiformal BCC (morphea-like lesions) is found in 88% of all recurrencies. Based upon the results of this study, the following therapeutic guidelines are recommended: Resection with tumor-free margins must be insisted on, particularly in any exposed surfaces of the body. Histological subtyping by the pathologist is required. After initially incomplete resection in certain histological subtypes, subsequent radical resection is not mandatory. Complete resection of sclerodermiformal BCC is mandatory, and continuous follow-up of these cases is recommended.
Language	ger
Pub Type(s)	Journal Article
PubMed ID	1618421

Advertise on this site.